Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $31.52 billion. The enterprise value is $32.41 billion.
| Market Cap | 31.52B |
| Enterprise Value | 32.41B |
Important Dates
The last earnings date was Tuesday, February 4, 2025, before market open.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Feb 18, 2025 |
Share Statistics
Xylem has 242.94 million shares outstanding. The number of shares has increased by 11.61% in one year.
| Current Share Class | 242.94M |
| Shares Outstanding | 242.94M |
| Shares Change (YoY) | +11.61% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 94.55% |
| Float | 241.20M |
Valuation Ratios
The trailing PE ratio is 35.54 and the forward PE ratio is 27.86. Xylem's PEG ratio is 2.26.
| PE Ratio | 35.54 |
| Forward PE | 27.86 |
| PS Ratio | 3.68 |
| Forward PS | 3.58 |
| PB Ratio | 2.96 |
| P/TBV Ratio | 111.37 |
| P/FCF Ratio | 33.46 |
| P/OCF Ratio | 24.95 |
| PEG Ratio | 2.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.85, with an EV/FCF ratio of 34.41.
| EV / Earnings | 36.42 |
| EV / Sales | 3.79 |
| EV / EBITDA | 19.85 |
| EV / EBIT | 30.26 |
| EV / FCF | 34.41 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.76 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.23 |
| Debt / FCF | 2.14 |
| Interest Coverage | 24.34 |
Financial Efficiency
Return on equity (ROE) is 8.45% and return on invested capital (ROIC) is 5.19%.
| Return on Equity (ROE) | 8.45% |
| Return on Assets (ROA) | 4.11% |
| Return on Invested Capital (ROIC) | 5.19% |
| Return on Capital Employed (ROCE) | 7.56% |
| Revenue Per Employee | $372,261 |
| Profits Per Employee | $38,696 |
| Employee Count | 23,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.31 |
Taxes
In the past 12 months, Xylem has paid $197.00 million in taxes.
| Income Tax | 197.00M |
| Effective Tax Rate | 18.12% |
Stock Price Statistics
The stock price has increased by +4.80% in the last 52 weeks. The beta is 1.07, so Xylem's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +4.80% |
| 50-Day Moving Average | 122.25 |
| 200-Day Moving Average | 130.95 |
| Relative Strength Index (RSI) | 61.64 |
| Average Volume (20 Days) | 1,366,376 |
Short Selling Information
The latest short interest is 3.08 million, so 1.27% of the outstanding shares have been sold short.
| Short Interest | 3.08M |
| Short Previous Month | 3.64M |
| Short % of Shares Out | 1.27% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 2.57 |
Income Statement
In the last 12 months, Xylem had revenue of $8.56 billion and earned $890.00 million in profits. Earnings per share was $3.65.
| Revenue | 8.56B |
| Gross Profit | 3.21B |
| Operating Income | 1.07B |
| Pretax Income | 838.00M |
| Net Income | 890.00M |
| EBITDA | 1.63B |
| EBIT | 1.07B |
| Earnings Per Share (EPS) | $3.65 |
Balance Sheet
The company has $1.12 billion in cash and $2.02 billion in debt, giving a net cash position of -$895.00 million or -$3.68 per share.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 2.02B |
| Net Cash | -895.00M |
| Net Cash Per Share | -$3.68 |
| Equity (Book Value) | 10.88B |
| Book Value Per Share | 43.79 |
| Working Capital | 1.77B |
Cash Flow
In the last 12 months, operating cash flow was $1.26 billion and capital expenditures -$321.00 million, giving a free cash flow of $942.00 million.
| Operating Cash Flow | 1.26B |
| Capital Expenditures | -321.00M |
| Free Cash Flow | 942.00M |
| FCF Per Share | $3.88 |
Margins
Gross margin is 37.51%, with operating and profit margins of 12.51% and 10.39%.
| Gross Margin | 37.51% |
| Operating Margin | 12.51% |
| Pretax Margin | 12.70% |
| Profit Margin | 10.39% |
| EBITDA Margin | 19.07% |
| EBIT Margin | 12.51% |
| FCF Margin | 11.00% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 1.23%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 1.23% |
| Dividend Growth (YoY) | 9.63% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 43.84% |
| Buyback Yield | -11.61% |
| Shareholder Yield | -10.37% |
| Earnings Yield | 2.82% |
| FCF Yield | 2.99% |
Analyst Forecast
The average price target for Xylem is $149.90, which is 15.55% higher than the current price. The consensus rating is "Buy".
| Price Target | $149.90 |
| Price Target Difference | 15.55% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 5.12% |
| EPS Growth Forecast (5Y) | 14.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.48 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.48 |
| Piotroski F-Score | 7 |